World Journal of Surgery

, Volume 30, Issue 4, pp 505–511

Cost/DALY Averted in a Small Hospital in Sierra Leone: What Is the Relative Contribution of Different Services?

  • Richard A. Gosselin
  • Amardeep Thind
  • Andrea Bellardinelli
Article

Abstract

Background

A cost-effective analysis (CEA) can be a useful tool to guide resource allocation decisions. However, there is a dearth of evidence on the cost/disability-adjusted life year (DALY) averted by health facilities in the developing world.

Methods

We conducted a study to calculate the costs and the DALYs averted by an entire hospital in Sierra Leone, using the method suggested by McCord and Chowdhury (Int J Gynaecol Obstet 2003;81:83–92).

Results

For the 3-month study period, total costs were calculated to be $369,774. Using the approach of McCord and Chowdhury, we calculated that 11,282 DALYs were averted during the study period, resulting in a cost/DALY averted of $32.78. This figure compares favorably to other non-surgical health interventions in developing countries. We found that while surgery accounts for 63% of total caseload, it contributes to 38% of the total DALYs averted.

Conclusions

Surgical treatment of some common pathologies in developing countries may be more cost-effective than previously thought, and our results provide evidence for the inclusion of surgery as part of the basic public health armamentarium in developing countries. However, these results are highly context-specific, and more research is needed from developing countries to further refine the methodology and analysis.

References

  1. 1.
    Adam T, Baltussen R, Tan Torres T, et al. Making Choices in Health: WHO Guide to Cost Effectiveness Analysis. Geneva, World Health Organization, 2003Google Scholar
  2. 2.
    Baltussen R, Sylla M, Mariotti SP. Cost-effectiveness analysis of cataract surgery: a global and regional analysis. Bull WHO 2004;82:338–345PubMedGoogle Scholar
  3. 3.
    Marseille E. Cost-effectiveness of cataract surgery in a public health eye care programme in Nepal. Bull WHO 1996;74:319–324PubMedGoogle Scholar
  4. 4.
    Singh AJ, Garner P, Floyd K. Cost-effectiveness of public-funded options for cataract surgery in Mysore, India. Lancet 2000;355:180–184CrossRefPubMedGoogle Scholar
  5. 5.
    Jamison D, Evans D, Alleyne G, et al., editors. Disease Control Priorities in Developing Countries. 2nd ed. Washington, DC, World Bank, Forthcoming 2006Google Scholar
  6. 6.
    McCord C, Chowdhury Q. A cost effective small hospital in Bangladesh: what it can mean for emergency obstetric care. Int J Gynaecol Obstet 2003;81:83–92CrossRefPubMedGoogle Scholar
  7. 7.
    Jamison DT, International Bank for Reconstruction and Development. Disease Control Priorities in Developing Countries. New York, Oxford University Press for the World Bank, 1993Google Scholar
  8. 8.
    Mills AJ, Kapalamula J, Chisimbi S. The cost of the district hospital: a case study in Malawi. Bull WHO 1993;71:329–339PubMedGoogle Scholar
  9. 9.
    Lewis MA, La Forgia GM, Sulvetta MB. Measuring public hospital costs: empirical evidence from the Dominican Republic. Soc Sci Med 1996;43:221–234CrossRefPubMedGoogle Scholar
  10. 10.
    Malalasekera AP, Ariyaratne MH, Fernando R, et al. Cost accounting in a surgical unit in a teaching hospital—a pilot study. Ceylon Med J 2003;48:71–74PubMedGoogle Scholar
  11. 11.
    Shepard D, Walsh J, Munar W, et al. Cost-effectiveness of ambulatory surgery in Cali, Colombia. Health Policy Plan 1993;8:136–142Google Scholar
  12. 12.
    Jha P, Bangoura O, Ranson K. The cost-effectiveness of forty health interventions in Guinea. Health Policy Plan 1998;13:249–262CrossRefPubMedGoogle Scholar
  13. 13.
    Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull WHO 1994;72:429–445PubMedGoogle Scholar
  14. 14.
    Murray CJL, Lopez AD, Harvard School of Public Health, World Health Organization., World Bank. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard School of Public Health for the World Health Organization and the World Bank; Distributed by Harvard University Press, 1996Google Scholar
  15. 15.
    Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ 1999;319:1423–1425PubMedGoogle Scholar
  16. 16.
    Bastian H. A consumer trip into the world of the DALY calculations: an Alice-in-Wonderland experience. Reprod Health Matters 2000;8:113–116CrossRefPubMedGoogle Scholar
  17. 17.
    Reidpath DD, Allotey PA, Kouame A, et al. Measuring health in a vacuum: examining the disability weight of the DALY. Health Policy Plan 2003;18:351–356CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2006

Authors and Affiliations

  • Richard A. Gosselin
    • 1
  • Amardeep Thind
    • 2
  • Andrea Bellardinelli
    • 3
  1. 1.School of Public HealthUniversity of CaliforniaBerkeleyUSA
  2. 2.Department of Family Medicine, Department of Epidemiology and BiostatisticsSchulich School of Medicine, University of Western OntarioLondonCanada
  3. 3.Logistician-Administrator, Emergency HospitalGoderich

Personalised recommendations